Income statement
USD
Annual
| Metric | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 102K | 21K |
| Gross Profit | 0 | 0 | 0 | 101K | -119K |
| Operating Income | -2M | -2M | -2M | -2M | -2M |
| EBITDA | -1M | -2M | 895K | -2M | -2M |
| Net Income | -3M | -42M | -6M | -4M | -5M |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.00001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 5, 2026
Coverage: 240 bars · Jun 23, 2025 → Jun 5, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Wellstar International, Inc. (WLSI) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 5, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +98.6%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +98.6%, free cash flow -99.0% with operating margin 0.0% and ROIC 49.0%. Stock Foundry combines WLSI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WLSI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
WLSI Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for WLSI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$21.5K
-78.8% YoY
FY Net Income
-$4.8M
-30.8% YoY
Free Cash Flow
-$2.3M
-45.9% YoY
Revenue Growth
+0.0%
EPS Growth
+98.6%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 102K | 21K |
| Gross Profit | 0 | 0 | 0 | 101K | -119K |
| Operating Income | -2M | -2M | -2M | -2M | -2M |
| EBITDA | -1M | -2M | 895K | -2M | -2M |
| Net Income | -3M | -42M | -6M | -4M | -5M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|
| Cash & Equivalents | 0 | 30K | 26K | 65K | 245K |
| Total Assets | 958K | 812K | 1M | 1M | 2M |
| Total Liabilities | 56M | 54M | 14M | 9M | 6M |
| Shareholder Equity | -55M | -53M | -13M | -7M | -4M |
| Total Debt | 51M | 50M | 10M | 8M | 5M |
| Net Debt | 51M | 50M | 10M | 7M | 5M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
2M
-11.4% YoY
Capital Expenditures
606K
-1113.0% YoY
Free Cash Flow
2M
-45.9% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
5.7%
Debt / Equity
-0.93x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.